DavidChesterSaneMD

Adult Congenital Heart Disease

Professor, Internal Medicine, Virginia Tech Carilion School of Medicine

Dr. Sane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

PubMed

74 citations
Clinical risks of thrombolytic therapy.
Robert M. Califf, Donald F. Fortin, Alan N. Tenaglia, David C. Sane
The American Journal of Cardiology. 1992-01-03
129 citations
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization☆
Scott D. Berkowitz, David C. Sane, Kristina N. Sigmon, Jane H. Shavender, Robert A. Harrington
Journal of the American College of Cardiology. 1998-08-01
148 citations
Angiogenic growth factors and hypertension.
David C. Sane, Lauren Anton, K. Bridget Brosnihan
Angiogenesis. 2004-01-01

Effect Of Oral Thalidomide On Inflammatory Markers And Endothelial FunctionNational Center For Research Resources2004
Angiostatin--Molecular Mechanisms And InteractionsNational Cancer Institute1999–2002
Vitronectin And Vascular Complications Of DiabNational Heart, Lung, And Blood Institute1999
Vitronectin And Vascular Complications Of DiabNational Heart, Lung, And Blood Institute1998
Angiostatin--Molecular Mechanisms And InteractionsNational Cancer Institute1998
Structure And Function Of VitronectinNational Heart, Lung, And Blood Institute1993–1997
Structure And Function Of VitronectinNational Heart, Lung, And Blood Institute1995
Role Of Vitronectin In Thrombosis And FibrinolysisNational Heart, Lung, And Blood Institute1992